Jin Medical Announces 20-for-1 Stock Split Effective Feb 8

TL;DR

**Jin Medical is doing a 20-for-1 stock split on Feb 8, making shares cheaper per unit.**

AI Summary

Jin Medical International Ltd. announced a 20-for-1 stock split, effective February 8, 2024, following shareholder approval on January 30, 2024. This means each existing share with a par value of US$0.001 will become 20 shares with a par value of US$0.00005. For investors, this matters because while the total value of their holdings remains the same, the stock price per share will likely decrease, potentially making the stock more accessible to a broader range of investors and increasing liquidity.

Why It Matters

A stock split typically lowers the per-share price, potentially making the stock more attractive to retail investors and increasing trading volume, which can improve liquidity.

Risk Assessment

Risk Level: low — A stock split is a corporate action that changes the number of shares and par value but does not fundamentally alter the company's market capitalization or an investor's total holding value.

Analyst Insight

Investors should note the effective date of February 8, 2024, and understand that while the number of shares they own will multiply by 20, the total value of their investment will remain unchanged immediately after the split. Monitor post-split trading activity for changes in liquidity and price stability.

Key Numbers

• 20 — subdivision ratio (each existing share will be divided into 20 new shares)
• US$0.001 — original par value (par value of ordinary shares before the subdivision)
• US$0.00005 — new par value (par value of ordinary shares after the subdivision)
• US$50,000 — authorized share capital (total authorized share capital after the subdivision)
• 1,000,000,000 — authorized shares (total number of authorized shares after the subdivision)

Key Players & Entities

• Jin Medical International Ltd. (company) — the registrant announcing the stock split
• US$0.001 (dollar_amount) — original par value per ordinary share
• US$0.00005 (dollar_amount) — new par value per ordinary share after subdivision
• February 8, 2024 (date) — effective date of the stock subdivision
• January 30, 2024 (date) — date of the extraordinary general meeting where shareholders approved the subdivision
• Transhare Corporation (company) — the Company's transfer agent

Forward-Looking Statements

• The per-share price of Jin Medical International Ltd. will decrease proportionally to the 20-for-1 split. (Jin Medical International Ltd.) — high confidence, target: February 8, 2024
• The liquidity and trading volume of Jin Medical International Ltd. shares may increase following the split. (Jin Medical International Ltd.) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.001 — d ordinary shares with a par value of US$0.001 each in the capital of the Company into
• $0.00005 — ) ordinary shares with a par value of US$0.00005 each (the “ Subdivision ”),
• $50,000 — rized share capital of the Company is US$50,000 divided into 1,000,000,000 shares with

Filing Documents

• ea192732-6k_jinmedical.htm (6-K) — 10KB
• 0001213900-24-010050.txt ( ) — 11KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. JIN MEDICAL INTERNATIONAL LTD. Date: February 5, 2024 By: /s/ Erqi Wang Erqi Wang Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR